Lansforsakringar Fondforvaltning AB publ Trims Position in HCA Healthcare, Inc. $HCA

Key Points

• Lansforsakringar Fondforvaltning AB publ has decreased its holdings in HCA Healthcare, Inc. by 1.8%, now owning 64,365 shares worth approximately $22.24 million.
• HCA Healthcare reported a strong quarterly earnings performance with $6.84 EPS, exceeding analysts' expectations, alongside a 6.4% year-over-year revenue increase.
• The company has announced a quarterly dividend of $0.72 per share, representing a yield of 0.7% with a payout ratio of 12.11%.

Lansforsakringar Fondforvaltning AB publ cut its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.8% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 64,365 shares of the company's stock after selling 1,177 shares during the period. Lansforsakringar Fondforvaltning AB publ's holdings in HCA Healthcare were worth $22,241,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of HCA. Brown Advisory Inc. raised its holdings in HCA Healthcare by 53.9% in the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock valued at $1,600,000 after buying an additional 1,622 shares during the period. Farther Finance Advisors LLC raised its stake in shares of HCA Healthcare by 26.9% in the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock valued at $395,000 after acquiring an additional 242 shares during the period. Oppenheimer Asset Management Inc. increased its holdings in HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock valued at $1,491,000 after purchasing an additional 105 shares during the last quarter. GAMMA Investing LLC lifted its stake in HCA Healthcare by 17.6% during the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock worth $1,704,000 after purchasing an additional 737 shares in the last quarter. Finally, J.W. Cole Advisors Inc. grew its stake in shares of HCA Healthcare by 145.3% in the first quarter. J.W. Cole Advisors Inc. now owns 3,550 shares of the company's stock valued at $1,227,000 after buying an additional 2,103 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on HCA. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Truist Financial lifted their target price on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Wells Fargo & Company decreased their price objective on HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating for the company in a research note on Thursday, August 14th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Finally, Wolfe Research cut shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat, HCA Healthcare has a consensus rating of "Moderate Buy" and a consensus target price of $401.83.

HCA Healthcare Stock Down 0.8%

HCA stock traded down $3.17 during midday trading on Monday, reaching $404.11. 996,401 shares of the company were exchanged, compared to its average volume of 1,110,551. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock's 50-day simple moving average is $376.92 and its 200 day simple moving average is $357.19. The company has a market cap of $94.56 billion, a price-to-earnings ratio of 16.99, a price-to-earnings-growth ratio of 1.27 and a beta of 1.41. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same period in the previous year, the company earned $5.50 earnings per share. HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.